Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $1.44 Million - $1.72 Million
6,713 New
6,713 $1.48 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $1.24 Million - $1.45 Million
-6,733 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $1.18 Million - $1.41 Million
6,554 Added 3661.45%
6,733 $1.24 Million
Q2 2021

Aug 16, 2021

SELL
$170.47 - $211.93 $606,020 - $753,411
-3,555 Reduced 95.21%
179 $32,000
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $574,811 - $652,889
3,734 New
3,734 $625,000
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $4,795 - $5,814
-48 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$92.74 - $125.82 $4,451 - $6,039
48 New
48 $6,000
Q1 2020

May 15, 2020

SELL
$79.39 - $115.35 $63,988 - $92,972
-806 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $6,578 - $8,008
-84 Reduced 9.44%
806 $71,000
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $346,929 - $398,563
-4,635 Reduced 83.89%
890 $71,000
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $420,231 - $667,475
5,525 New
5,525 $431,000
Q3 2018

Nov 14, 2018

SELL
$113.81 - $129.46 $227 - $258
-2 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $202 - $236
2 New
2 $0
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $3,001 - $4,254
-28 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$118.58 - $151.28 $1,897 - $2,420
16 Added 133.33%
28 $4,000
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $1,375 - $1,641
12
12 $1,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.